The Column Group | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/The Column Group/Activity

The Column Group Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Led InduPro's $77M Series B financing to advance its lead oncology program IDP-001 into Phase 1.

InduPro

InduPro The Column Group

biospace.comAUG 12, 2026

AUG 12, 2026

Investment

TCGX co-led Vaderis Therapeutics' oversubscribed $152.5M Series B financing to fund the global Phase 3 HEROIC study.

Vaderis Therapeutics

Vaderis Therapeutics The Column Group

biospace.comAUG 11, 2026

AUG 11, 2026

Exit

Portfolio company Neurona Therapeutics was acquired by UCB for up to $1.15B.

Neurona Therapeutics

Neurona Therapeutics The Column Group

biospace.comAPR 17, 2026

APR 17, 2026

Exit

Portfolio company RAPT Therapeutics was acquired by GSK for an estimated equity value of $2.2B.

RAPT Therapeutics

RAPT Therapeutics The Column Group

gsk.comJAN 20, 2026

JAN 20, 2026

Investment

Co-led Atavistik Bio's $120M Series B financing alongside Nextech Invest to advance HHT and MPN programs.

Atavistik Bio

Atavistik Bio The Column Group

globenewswire.comDEC 18, 2025

DEC 18, 2025

New Fund

TCG Crossover announced an oversubscribed $1.3B TCGX Fund III, its third crossover fund in four years.

TCGX Fund III

The Column Group

businesswire.comOCT 6, 2025

OCT 6, 2025

New Fund

TCG Labs-Soleil raised an additional $400M and expanded its R&D capabilities globally, including into China.

TCG Labs-Soleil additional $400M raise

The Column Group

globenewswire.comJUL 24, 2025

JUL 24, 2025

Exit

Portfolio company Carmot Therapeutics entered a definitive merger agreement to be acquired by Roche for $2.7B upfront plus up to $400M in milestones.

Carmot Therapeutics

Carmot Therapeutics The Column Group

globenewswire.comDEC 4, 2023

DEC 4, 2023